【24h】

Photosensitizer Quantitation in Vivo by Fluorescence Micro-sampling

机译:荧光显微采样体内光敏剂定量

获取原文
获取原文并翻译 | 示例

摘要

Photodynamic therapy can provide a reliable method of tumor destructionw hen the appropriate dosimetry is applied. Current dosimetry practice involves quantification of the drug and light doses applied to the tumor, but it would be desirable to monitor in vivo light and drug levels to provide the most accurate determination of dosimetry. In vivo measurements can be used to minimize variations in treatment response due to inter-animal variability, by providing animal-specific or patient-specific treatment planning. This study reports on the development of a micro-sampling method to measure fluorescence from tissue, which is not significantly affected by the tissue optical properties. The system measures fluorescence from the surface of a tissue, using a fiber bundle composed of individual 100 micron fibers which are all spaced apart by 700 microns from one another at the tissue contact end. This design provides sampling of the fluorescence at multiple sites to increase the signal intensity, while maintaining a micro-sampling of the tissue volume just below the surface. The calibration studies here indicate that the 1/e sampling depth is near 60 microns when measured in optical phantoms, which are similar to typical tissue properties. The probe fluorescence signal is independent of blood concentration up to a maximum of 10percent blood by volume, which is similar to most tumor tissue. Animal tests indicate that the sensitivity to drug concentration is essentially the same in when measured in murine liver and muscle tissues, both in vivo and ex vivo. These preliminary calibration results suggest that the probe can be used to measure photosensitizer uptake in vivo non-invasively and rapidly via conversion of fluorescence intensity to photosensitizer concentration.
机译:当应用适当的剂量测定法时,光动力疗法可以提供一种可靠的消灭肿瘤的方法。当前的剂量学实践涉及对应用于肿瘤的药物和光剂量的量化,但是希望监控体内的光和药物水平以提供最准确的剂量学测定。通过提供动物特定或患者特定的治疗计划,可以将体内测量值用于最大程度地减少由于动物间变异而引起的治疗反应差异。这项研究报告了一种用于测量组织荧光的微采样方法的发展,该方法不受组织光学特性的显着影响。该系统使用由单独的100微米纤维组成的纤维束来测量组织表面的荧光,这些纤维束在组织接触端彼此间隔700微米。这种设计可在多个位置对荧光进行采样,以增加信号强度,同时保持表面下方组织体积的微采样。此处的校准研究表明,在光学体模中进行测量时,1 / e采样深度接近60微米,这与典型的组织特性相似。探针荧光信号与血液浓度无关,最多可达到体积的10%,这与大多数肿瘤组织相似。动物试验表明,在小鼠肝脏和肌肉组织中进行体内和离体测量时,对药物浓度的敏感性基本相同。这些初步的校准结果表明,该探针可用于将荧光强度转换为光敏剂浓度,从而非侵入性地快速测量体内光敏剂的摄取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号